Answers are grounded in this paper and cite their sources.
Through pan-cancer screening, we found that many protein biomarkers were prognostic for patients' survival in KIRC. Stage-specific survival biomarkers in KIRC were also identified. Our study indicated that these protein biomarkers might have potential clinical value in terms of predicting survival in KIRC patients and developing individualized treatment strategies. Importantly, we found many biomarkers in KIRC at both the mRNA expression level and the protein expression level. These biomarkers shared a significant overlap, indicating that they were technically replicable.
No takes yet. Share an insight, caveat, or question.
Han et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: